80164-10-9

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 304-59-6 Rochelle's salt 
• 80164-09-6 (20S)-(20-Methyl-5-pregnen-1α,3β,21-triol)-21-p-toluolsulfonat 
• 66875-29-4 (20S)-(20-Methyl-5-pregnen-1α,3β,21-triol)-1,3-diacetat-21-p-toluolsulfonat 
• 66875-22-7 (20S)-20-Methyl-5-pregnen-1α,3β,21-triol 
• 66875-27-2 (20S)-20-Methyl-1α,3β-bis<(tetrahydropyran-2-yl)oxy>-5-pregnen-21-saeure-methylester 
• 81481-28-9 (20S)-(20-Methyl-1α,3β-bis<(tetrahydropyran-2-yl)oxy>-5-pregnen-21-ol)acetat 
• 66875-25-0 (20S)-1α,3β-Dihydroxy-20-methyl-5-pregnen-21-saeure-methylester 
• 81481-27-8 (20S)-(20-Methyl-5-pregnen-1α,3β,21-triol)-21-acetat 
• 66875-24-9 (20S)-1α,3β-Dihydroxy-20-methyl-5-pregnen-21-saeure 
• 98-59-9 p-toluenesulfonyl chloride 
• 66875-23-8 (20S)-1α,3β-Diacetoxy-20-methyl-5-pregnen-21-al 
• 66875-21-6 (20S)-(20-Methyl-5-pregnen-1α,3β,21-triol)-1α,3β-diacetat 
• 66875-28-3 (20S)-(20-Methyl-1α,3β-bis<(tetrahydropyran-2-yl)oxy>-5-pregnen-21-ol) 

Downstream Products

• 26358-75-8 1α,3β-dihydroxycholest-5-ene 

Relevant academic research and scientific papers

Process and intermediates for the synthesis of vitamin D3 metabolites

The present disclosure is directed to a process and intermediates for the synthesis of Vitamin D3 metabolites such as 1,25-dihydroxycholecalciferol, 25-hydroxycholecalciferol and 24R,25-dihydroxycholecalciferol from 17-keto steroids via interme

Process for the manufacture of cholesterol derivatives

The present disclosure is directed to a process for the preparation of cholesterol derivatives from corresponding 21-hydroxymethyl steroidal compounds.